Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study sheds light on rare genetic cause of intellectual disability

NCT ID NCT03718910

First seen Apr 20, 2026 · Last updated Jun 19, 2026 · Updated 12 times

Summary

This study looked at 15 people with changes in the DDX3X gene, a known cause of intellectual disability and sometimes autism. Researchers used interviews, play-based assessments, and genetic tests to better understand the condition. The goal was to describe the range of symptoms, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The Seaver Autism Center for Research and Treatment

    New York, New York, 10029, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could provide a clearer understanding of DDX3X syndrome and its link to autism and intellectual disability.

What could go wrong

This is a small, observational study with only 15 participants, so findings may not apply to everyone with DDX3X variants. It aims to describe, not treat, the condition.

Conditions

The condition(s) this trial relates to.

Autism Spectrum Disorder developmental disability intellectual disability learning disability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.